NASDAQ : OLMA
Olema Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 7.33 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 641.36M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 30.94M | 21.00M | 17.74M | 18.82M | 24.71M | 20.39M |
| Research & Development | 190.19M | 147.70M | 119.52M | 86.14M | 82.27M | 51.10M |
| Operating Expenses | 221.13M | 168.70M | 137.26M | 104.96M | 106.99M | 71.49M |
| Operating Income | -221.13M | -168.70M | -137.26M | -104.96M | -106.99M | -71.49M |
| Interest & Investment Income | 16.94M | 16.22M | 12.68M | 8.32M | 2.23M | 442.00K |
| Other Non Operating Income (Expenses) | -382.00K | 23.00K | 102.00K | -19.00K | -27.00K | -47.00K |
| EBT Excluding Unusual Items | -204.57M | -152.45M | -124.47M | -96.66M | -104.79M | -71.10M |
| Other Unusual Items | -10.00M | -5.00M | ||||
| Pretax Income | -204.57M | -162.45M | -129.47M | -96.66M | -104.79M | -71.10M |
| Net Income | -204.57M | -162.45M | -129.47M | -96.66M | -104.79M | -71.10M |
| Net Income to Common | -204.57M | -162.45M | -129.47M | -96.66M | -104.79M | -71.10M |
| Shares Outstanding (Basic) | 96.09M | 87.01M | 58.74M | 45.25M | 40.00M | 39.52M |
| Shares Outstanding (Diluted) | 96.09M | 87.01M | 58.74M | 45.25M | 40.00M | 39.52M |
| EPS (Basic) | -2.13 | -1.87 | -2.20 | -2.14 | -2.62 | -1.80 |
| EPS (Diluted) | -2.13 | -1.87 | -2.20 | -2.14 | -2.62 | -1.80 |
| Free Cash Flow | -164.96M | -146.72M | -104.51M | -83.73M | -82.43M | -52.27M |
| Free Cash Flow Per Share | -1.72 | -1.69 | -1.78 | -1.85 | -2.06 | -1.32 |
| EBITDA | -220.68M | -168.21M | -136.87M | -104.58M | -106.63M | -71.33M |
| D&A For EBITDA | 451.00K | 490.00K | 393.00K | 377.00K | 357.00K | 163.00K |
| EBIT | -221.13M | -168.70M | -137.26M | -104.96M | -106.99M | -71.49M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 48.60M | 48.30M | 139.48M | 68.54M | 23.70M | 13.81M |
| Short-Term Investments | 412.47M | 457.14M | 294.61M | 193.27M | 180.72M | 273.44M |
| Cash & Short-Term Investments | 461.07M | 505.44M | 434.09M | 261.81M | 204.42M | 287.25M |
| Other Receivables | 3.17M | 4.06M | 2.12M | 673.00K | 319.00K | 130.00K |
| Receivables | 3.17M | 4.06M | 2.12M | 673.00K | 319.00K | 130.00K |
| Prepaid Expenses | 5.64M | 4.37M | 1.90M | 2.35M | 2.64M | 2.97M |
| Other Current Assets | 1.59M | 366.00K | 1.68M | 1.52M | 332.00K | |
| Total Current Assets | 469.88M | 515.45M | 438.47M | 266.51M | 208.90M | 290.69M |
| Property, Plant & Equipment | 1.02M | 1.42M | 2.06M | 3.26M | 2.50M | 4.72M |
| Long-Term Deferred Charges | 892.00K | 683.00K | ||||
| Other Long-Term Assets | 14.90M | 15.67M | 9.76M | 7.17M | 4.25M | 540.00K |
| Total Assets | 486.58M | 533.43M | 450.98M | 276.94M | 215.65M | 295.94M |
| Accounts Payable | 1.67M | 9.25M | 4.46M | 2.70M | 374.00K | 23.00K |
| Accrued Expenses | 50.67M | 41.42M | 36.13M | 17.86M | 15.09M | 7.80M |
| Current Portion of Leases | 660.00K | 1.12M | 1.17M | 988.00K | 1.01M | 931.00K |
| Current Income Taxes Payable | 17.00K | 73.00K | 68.00K | 88.00K | ||
| Other Current Liabilities | 172.00K | |||||
| Total Current Liabilities | 53.01M | 51.80M | 41.76M | 21.62M | 16.55M | 9.02M |
| Long-Term Debt | 3.00M | 3.00M | ||||
| Long-Term Leases | 69.00K | 257.00K | 1.43M | 1.55M | 2.36M | |
| Total Liabilities | 56.01M | 54.87M | 42.02M | 23.05M | 18.10M | 11.38M |
| Common Stock | 8.00K | 8.00K | 7.00K | 4.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 1.15B | 1.08B | 843.92M | 559.18M | 408.33M | 388.90M |
| Retained Earnings | -713.85M | -597.56M | -435.11M | -305.63M | -208.98M | -104.19M |
| Comprehensive Income & Other | -947.00K | 621.00K | 143.00K | 347.00K | -1.81M | -149.00K |
| Total Common Equity | 430.56M | 478.56M | 408.96M | 253.90M | 197.55M | 284.57M |
| Shareholders' Equity | 430.56M | 478.56M | 408.96M | 253.90M | 197.55M | 284.57M |
| Total Liabilities & Equity | 486.58M | 533.43M | 450.98M | 276.94M | 215.65M | 295.94M |
| Total Debt | 3.66M | 4.19M | 1.43M | 2.42M | 2.56M | 3.29M |
| Net Cash (Debt) | 457.41M | 501.24M | 432.66M | 259.39M | 201.86M | 283.96M |
| Net Cash Per Share | 4.76 | 5.76 | 7.37 | 5.73 | 5.05 | 7.18 |
| Filing Date Shares Outstanding | 87.50M | 87.16M | 68.33M | 55.91M | 40.63M | 39.85M |
| Total Common Shares Outstanding | 87.45M | 81.38M | 74.31M | 54.99M | 40.29M | 39.84M |
| Working Capital | 416.86M | 463.65M | 396.71M | 244.89M | 192.35M | 281.67M |
| Book Value Per Share | 4.92 | 5.88 | 5.50 | 4.62 | 4.90 | 7.14 |
| Tangible Book Value | 429.78M | 478.56M | 408.96M | 253.90M | 197.55M | 284.57M |
| Tangible Book Value Per Share | 4.91 | 5.88 | 5.50 | 4.62 | 4.90 | 7.14 |
| Machinery | 1.70M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -204.57M | -162.45M | -129.47M | -96.66M | -104.79M | -71.10M |
| Depreciation & Amortization | 451.00K | 490.00K | 393.00K | 377.00K | 357.00K | 163.00K |
| Loss (Gain) From Sale of Assets | 9.00K | 111.00K | ||||
| Loss (Gain) From Sale of Investments | 276.00K | |||||
| Stock-Based Compensation | 31.57M | 17.59M | 22.58M | 17.26M | 18.83M | 15.91M |
| Other Operating Activities | -3.77M | -5.12M | -7.03M | -4.23M | 514.00K | 1.22M |
| Change in Accounts Payable | 578.00K | 4.60M | 2.51M | 2.32M | 351.00K | -683.00K |
| Change in Other Net Operating Assets | 11.00M | -1.82M | 6.65M | -2.91M | 2.67M | 3.51M |
| Operating Cash Flow | -164.74M | -146.72M | -104.35M | -83.73M | -82.06M | -50.69M |
| Capital Expenditures | -221.00K | -159.00K | -363.00K | -1.57M | ||
| Sale of Property, Plant & Equipment | 14.00K | |||||
| Investment in Securities | -99.32M | -155.76M | -93.37M | -4.87M | 91.84M | -273.86M |
| Investing Cash Flow | -99.54M | -155.76M | -93.53M | -4.85M | 91.48M | -275.44M |
| Long-Term Debt Issued | 3.00M | |||||
| Net Debt Issued (Repaid) | 3.00M | |||||
| Issuance of Common Stock | 273.54M | 227.92M | 275.48M | 133.41M | 476.00K | 1.39M |
| Other Financing Activities | -13.13M | -19.62M | -6.66M | |||
| Financing Cash Flow | 260.40M | 211.30M | 268.82M | 133.41M | 476.00K | 1.39M |
| Net Cash Flow | -3.87M | -91.18M | 70.94M | 44.84M | 9.89M | -324.74M |
| Free Cash Flow | -164.96M | -146.72M | -104.51M | -83.73M | -82.43M | -52.27M |
| Free Cash Flow Per Share | -1.72 | -1.69 | -1.78 | -1.85 | -2.06 | -1.32 |
| Levered Free Cash Flow | -89.06M | -82.90M | -42.70M | -43.10M | -41.64M | -26.52M |
| Unlevered Free Cash Flow | -89.06M | -82.90M | -42.70M | -43.10M | -41.64M | -26.52M |
| Change in Working Capital | 11.58M | 2.77M | 9.16M | -589.00K | 3.02M | 2.83M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 618.61M | 1.97B | 430.06M | 766.34M | 98.27M | 372.01M |
| Enterprise Value | 161.20M | 1.64B | 216.99M | 492.07M | -121.50M | 66.06M |
| Last Close Price | 7.07 | 25.00 | 5.83 | 14.03 | 2.45 | 9.36 |
| PB Ratio | 1.44 | 4.11 | 1.05 | 3.02 | 0.50 | 1.31 |
| P/TBV Ratio | 1.44 | 4.11 | 1.05 | 3.02 | 0.50 | 1.31 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.06 | -1.05 | -1.06 | -1.02 | -1.02 | -1.00 |
| Net Debt / EBITDA Ratio | 2.07 | 2.98 | 3.16 | 2.48 | 1.89 | 3.98 |
| Net Debt / FCF Ratio | 2.77 | 3.42 | 4.14 | 3.10 | 2.45 | 5.43 |
| Quick Ratio | 8.76 | 9.84 | 10.45 | 12.14 | 12.37 | 31.86 |
| Current Ratio | 8.86 | 9.95 | 10.50 | 12.33 | 12.62 | 32.23 |
| Return on Equity (ROE) | -52.74% | -36.61% | -39.06% | -42.82% | -43.47% | -22.83% |
| Return on Assets (ROA) | -31.82% | -21.42% | -23.57% | -26.63% | -26.14% | -13.99% |
| Return on Capital Employed (ROCE) | -51.00% | -35.00% | -33.50% | -41.10% | -53.70% | -24.90% |
| Earnings Yield | -30.11% | -8.26% | -30.11% | -12.61% | -106.63% | -19.11% |
| FCF Yield | -26.67% | -7.46% | -24.30% | -10.93% | -83.88% | -14.05% |
| Buyback Yield / Dilution | -30.72% | -48.11% | -29.83% | -13.13% | -1.19% | -462.91% |